跳至主要内容
临床试验/IRCT201311104190N2
IRCT201311104190N2已完成未知

Evaluation the Effects of Valerian and Placebo on Prevention of Cognitive Impairment after Coronary Artery Surgery

Vice chancellor for research, Islamic Azad University, Sari Branch0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
30 years 至 70 years(—)
性别
All

入选标准

  • 1.Patients aged between 30-70 years.
  • 2.Coronary artery bypass surgery with cardiopulmonary bypass
  • Exclusion criteria:
  • 1.Other simultaneous cardiac surgery (e.g., Valve replacement)
  • 2.Symptomatic cerebrovascular disease
  • 3.Alcoholism
  • 4.Psychiatric illness (any clinical diagnosis requiring therapy)
  • 5.Drug abuse
  • 6.Hepatic insufficiency (liver function tests>1.5 times the upper limit of normal)
  • 7.Severe pulmonary insufficiency (requiring home oxygen therapy)
  • 8.Renal failure (serum creatinine>2mg/dl)
  • 9.Reluctance to do a cognitive test performance
  • 10.Previous heart surgery
  • 11.Preoperative left ventricular ejection fraction<30%
  • 12.Sensitivity to valerian

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research, Islamic Azad University, Sari Branch

相似试验